Hauke Walter

2.3k total citations
57 papers, 1.6k citations indexed

About

Hauke Walter is a scholar working on Infectious Diseases, Virology and Clinical Psychology. According to data from OpenAlex, Hauke Walter has authored 57 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Infectious Diseases, 35 papers in Virology and 14 papers in Clinical Psychology. Recurrent topics in Hauke Walter's work include HIV/AIDS drug development and treatment (37 papers), HIV Research and Treatment (34 papers) and HIV/AIDS Research and Interventions (23 papers). Hauke Walter is often cited by papers focused on HIV/AIDS drug development and treatment (37 papers), HIV Research and Treatment (34 papers) and HIV/AIDS Research and Interventions (23 papers). Hauke Walter collaborates with scholars based in Germany, Belgium and Switzerland. Hauke Walter's co-authors include Bárbara Schmidt, Klaus Korn, Rolf Kaiser, Thomas Lengauer, Daniel Hoffmann, Niko Beerenwinkel, Joachim Selbig, Michael Zaudig, Anne–Mieke Vandamme and Klaus Überla and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Bioinformatics and PLoS ONE.

In The Last Decade

Hauke Walter

57 papers receiving 1.6k citations

Peers

Hauke Walter

VIROL

EPIDE

HEPAT

Joseph Kessler United States

Hans Rempel United States

Hongtao Xu Canada

R. W. Sidwell United States

Steven Specter United States

H. Friedman United States

Lorraine Jones‐Brando United States

Chiara Riva Italy

Anna Albecka United Kingdom

Rémy Durand France

Joseph Kessler United States

Hauke Walter

455 ×0.4

1.0k ×1.1

VIROL

419 ×1.8

EPIDE

41 ×0.2

HEPAT

479 ×2.4

Citations per year, relative to Hauke Walter Hauke Walter (= 1×) peers Joseph Kessler

Countries citing papers authored by Hauke Walter

Since Specialization

Citations

This map shows the geographic impact of Hauke Walter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hauke Walter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hauke Walter more than expected).

Fields of papers citing papers by Hauke Walter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hauke Walter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hauke Walter. The network helps show where Hauke Walter may publish in the future.

Co-authorship network of co-authors of Hauke Walter

This figure shows the co-authorship network connecting the top 25 collaborators of Hauke Walter. A scholar is included among the top collaborators of Hauke Walter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hauke Walter. Hauke Walter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gapsys, Vytautas, Hauke Walter, Eva Heger, et al.. (2020). Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors. Retrovirology. 17(1). 13–13. 14 indexed citations

Schiele, Miriam A., Christiane M. Thiel, Hauke Walter, et al.. (2020). Oxytocin Receptor Gene DNA Methylation: A Biomarker of Treatment Response in Obsessive-Compulsive Disorder?. Psychotherapy and Psychosomatics. 90(1). 57–63. 24 indexed citations

Widera, Marek, Martin Däumer, Hauke Walter, et al.. (2017). HIV-1 persistent viremia is frequently followed by episodes of low-level viremia. Medical Microbiology and Immunology. 206(3). 203–215. 13 indexed citations

Pironti, Alejandro, Nico Pfeifer, Rolf Kaiser, Hauke Walter, & Thomas Lengauer. (2014). Improved therapy‐success prediction with GSS estimated from clinical HIV‐1 sequences. Journal of the International AIDS Society. 17(4S3). 19743–19743. 4 indexed citations

Walter, Hauke, Ina Jahn, Katarina Stengler, et al.. (2014). Does “thinking about thinking” interfere with memory? An experimental memory study in obsessive–compulsive disorder. Journal of Anxiety Disorders. 28(7). 679–686. 6 indexed citations

Ehret, Robert, Hauke Walter, Patrick Ingiliz, et al.. (2014). Safety analysis of raltegravir/truvada regimen in HIV/HCV co‐infected patients without switchback after HCV treatment. Journal of the International AIDS Society. 17(4S3). 19644–19644. 1 indexed citations

Sierra, Saleta & Hauke Walter. (2012). Targets for Inhibition of HIV Replication: Entry, Enzyme Action, Release and Maturation. Intervirology. 55(2). 84–97. 30 indexed citations

Vandamme, Anne–Mieke, Ricardo Camacho, Francesca Ceccherini‐Silberstein, et al.. (2011). European recommendations for the clinical use of HIV drug resistance testing: 2011 update.. PubMed. 13(2). 77–108. 104 indexed citations

Wiesmann, Frank, Robert Ehret, Hauke Walter, et al.. (2011). The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?. AIDS Research and Therapy. 8(1). 7–7. 10 indexed citations

10.

Sierra, Saleta, Nadine Lübke, Hauke Walter, et al.. (2011). The SnoB study: frequency of baseline raltegravir resistance mutations prevalence in different non-B subtypes. Medical Microbiology and Immunology. 200(4). 225–232. 11 indexed citations

11.

Singer, Andrea, et al.. (2011). Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: A reanalysis of data from a controlled clinical trial. Phytomedicine. 18(8-9). 739–742. 22 indexed citations

12.

Weisser, Hendrik, André Altmann, Saleta Sierra, et al.. (2010). Only Slight Impact of Predicted Replicative Capacity for Therapy Response Prediction. PLoS ONE. 5(2). e9044–e9044. 10 indexed citations

13.

Spriewald, Bernd M., Silke Bergmann, Klaus Korn, et al.. (2010). Influence of Major HIV-1 Protease Inhibitor Resistance Mutations on CTL Recognition. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(2). 109–117. 12 indexed citations

14.

Rechter, Sabine, Sabrina Auerochs, Stefanie Thulke, et al.. (2006). Antiviral activity of Arthrospira-derived spirulan-like substances. Antiviral Research. 72(3). 197–206. 114 indexed citations

15.

Mavrogiorgou, Paraskevi, Georg Juckel, Thomas Frodl, et al.. (2002). P300 subcomponents in obsessive-compulsive disorder. Journal of Psychiatric Research. 36(6). 399–406. 43 indexed citations

16.

Schmidt, Bárbara, Klaus Korn, & Hauke Walter. (2002). Technologies for measuring HIV-1 drug resistance. HIV Clinical Trials. 3(3). 227–236. 3 indexed citations

17.

Walter, Hauke, Thomas Harrer, Matthias Schmitt, et al.. (2002). No Evidence for Persistence of Multidrug-Resistant Viral Strains After a 7-Month Treatment Interruption in an HIV-1–Infected Individual. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31(2). 137–146. 13 indexed citations

18.

Beerenwinkel, Niko, Bárbara Schmidt, Hauke Walter, et al.. (2001). Identifying drug resistance-associated patterns in HIV genotypes. MPG.PuRe (Max Planck Society). 126–130. 1 indexed citations

19.

Duwe, Susanne, Doris Altmann, Osamah Hamouda, et al.. (2001). Frequency of Genotypic and Phenotypic Drug-Resistant HIV-1 Among Therapy-Naive Patients of the German Seroconverter Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(3). 266–273. 81 indexed citations

20.

Walter, Hauke, Bárbara Schmidt, Klaus Korn, et al.. (1999). Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors. Journal of Clinical Virology. 13(1-2). 71–80. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact